Gilead says additional data on remdesivir shows improved clinical recovery
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Gilead says additional data on remdesivir shows improved clinical recovery

Coronavirus chronicle

Reuters
10 July, 2020, 07:05 pm
Last modified: 10 July, 2020, 09:22 pm

Related News

  • Gilead's remdesivir reduces Covid-19 mortality risk
  • Gilead to buy cancer drugmaker Immunomedics for $21 billion
  • Gilead files US marketing application for remdesivir
  • Pfizer signs deal to supply Gilead's remdesivir for Covid-19
  • UK's Hikma starts manufacturing Covid-19 drug remdesivir for Gilead

Gilead says additional data on remdesivir shows improved clinical recovery

The company said the finding requires confirmation in prospective clinical trials

Reuters
10 July, 2020, 07:05 pm
Last modified: 10 July, 2020, 09:22 pm
In this photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States.AP Photo
In this photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States.AP Photo

Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery and reduced the risk of death in Covid-19 patients.

The company said the finding requires confirmation in prospective clinical trials.

Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as in the study.

Findings from the analysis of its late-stage study showed that 74.4 percent of remdesivir-treated patients recovered by Day 14 versus 59.0 percent of patients receiving standard of care, the company said.

The mortality rate for patients treated with remdesivir in the analysis was 7.6 percent at Day 14, compared with 12.5 percent among patients not on remdesivir.

Gilead shares were up nearly 2 percent at $76.14 in trading before the bell.

Top News

Gilead

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Students suffer over costlier food at public university canteens
    Students suffer over costlier food at public university canteens
  • Infographic: TBS
    Businesses reel under soaring costs
  • Photo: Mumit M/TBS
    What delays infrastructure projects in Bangladesh?

MOST VIEWED

  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop

Related News

  • Gilead's remdesivir reduces Covid-19 mortality risk
  • Gilead to buy cancer drugmaker Immunomedics for $21 billion
  • Gilead files US marketing application for remdesivir
  • Pfizer signs deal to supply Gilead's remdesivir for Covid-19
  • UK's Hikma starts manufacturing Covid-19 drug remdesivir for Gilead

Features

Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

1h | Panorama
Photo: Mumit M/TBS

What delays infrastructure projects in Bangladesh?

2h | Panorama
Foods that you should never put in the refrigerator

Foods that you should never put in the refrigerator

2h | Food
Beef Kunafa: A treat for beef and cheese lovers

Beef Kunafa: A treat for beef and cheese lovers

3h | Food

More Videos from TBS

Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

3h | Videos
How to prepare for a job

How to prepare for a job

4h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

16h | Videos
How many countries have nuclear weapons and how many are there?

How many countries have nuclear weapons and how many are there?

16h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab